These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Tan G; Li J; Song Y; Yu Y; Liu D; Pan W Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929 [TBL] [Abstract][Full Text] [Related]
43. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization. Katara R; Sachdeva S; Majumdar DK Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225 [TBL] [Abstract][Full Text] [Related]
45. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation. Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294 [TBL] [Abstract][Full Text] [Related]
46. Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model. Huang L; Gao H; Wang Z; Zhong Y; Hao L; Du Z Int J Nanomedicine; 2021; 16():3613-3631. PubMed ID: 34079253 [TBL] [Abstract][Full Text] [Related]
47. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin. Durairaj C; Kadam RS; Chandler JW; Hutcherson SL; Kompella UB Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5804-16. PubMed ID: 20484584 [TBL] [Abstract][Full Text] [Related]
48. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats. Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367 [TBL] [Abstract][Full Text] [Related]
49. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies. Rathod LV; Kapadia R; Sawant KK Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741 [TBL] [Abstract][Full Text] [Related]
50. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections. Togami K; Chono S; Morimoto K Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381 [TBL] [Abstract][Full Text] [Related]
51. Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease. Modi D; Nirmal J; Warsi MH; Bhatia M; Hasan N; Kesharwani P; Jain GK Colloids Surf B Biointerfaces; 2022 Mar; 211():112255. PubMed ID: 34942465 [TBL] [Abstract][Full Text] [Related]
52. A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye. Baba K; Tanaka Y; Kubota A; Kasai H; Yokokura S; Nakanishi H; Nishida K J Control Release; 2011 Aug; 153(3):278-87. PubMed ID: 21549167 [TBL] [Abstract][Full Text] [Related]
53. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822 [TBL] [Abstract][Full Text] [Related]
54. Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome. Maulvi FA; Soni TG; Shah DO J Biomater Sci Polym Ed; 2015; 26(15):1035-50. PubMed ID: 26176811 [TBL] [Abstract][Full Text] [Related]
55. Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents. Brugnera M; Vicario-de-la-Torre M; González-Cela Casamayor MA; López-Cano JJ; Bravo-Osuna I; Huete-Toral F; González Rubio ML; Carracedo G; Molina-Martínez IT; Andrés-Guerrero V; Herrero-Vanrell R Drug Deliv Transl Res; 2024 Oct; 14(10):2804-2822. PubMed ID: 38602615 [TBL] [Abstract][Full Text] [Related]
56. The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model. Kim KA; Hyun LC; Jung SH; Yang SJ Mol Vis; 2016; 22():284-93. PubMed ID: 27110091 [TBL] [Abstract][Full Text] [Related]
57. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor. El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311 [TBL] [Abstract][Full Text] [Related]
58. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System. Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593 [TBL] [Abstract][Full Text] [Related]
59. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
60. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]